January 12, 2021 Medtech deal-making stands firm in difficult times It takes more than a pandemic to stop medical device companies merging.
September 16, 2020 With its liquid biopsy approval, Foundation Medicine takes on Guardant The first pan-cancer approval might have gone to Guardant, but Roche’s subsidiary’s blood test appears to be able to find more markers.
July 09, 2020 Medical device mergers on pause 2019 was an average year for medtech M&A. 2020, not so much.
June 23, 2020 Invitae ends medtech merger drought with ArcherDX deal The cash-and-stock deal, worth $886m up front, is the first major liquid biopsy acquisition since Roche bought Foundation Medicine.